Research Articles
Research articles concerning CKD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in CKDdb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
231 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A00101 | 17623760 | J Clin Endocrinol Metab | Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals. | 2007 | Details |
A00102 | 17652184 | Mol Endocrinol | Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. | 2008 | Details |
A00103 | 17671651 | J Clin Invest | Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. | 2007 | Details |
A00104 | 17726085 | J Clin Endocrinol Metab | Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. | 2008 | Details |
A00105 | 17906635 | Nat Med | Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. | 2007 | Details |
A00106 | 18008060 | Diabetologia | The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. | 2008 | Details |
A00107 | 18025464 | Proc Natl Acad Sci U S A | Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes. | 2008 | Details |
A00108 | 18097733 | J Hum Genet | Association of TCF7L2 polymorphisms with susceptibility to type 2 diabetes in 4,087 Japanese subjects. | 2008 | Details |
A00109 | 18231124 | Eur J Hum Genet | HHEX gene polymorphisms are associated with type 2 diabetes in the Dutch Breda cohort. | 2008 | Details |
A00110 | 18323454 | Science | Hepatic glucose sensing via the CREB coactivator CRTC2. | 2008 | Details |
A00111 | 18364377 | J Clin Endocrinol Metab | The -250G>A promoter variant in hepatic lipase associates with elevated fasting serum high-density lipoprotein cholesterol modulated by interaction with physical activity in a study of 16,156 Danish subjects. | 2008 | Details |
A00112 | 18477659 | J Clin Endocrinol Metab | Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. | 2008 | Details |
A00113 | 18596924 | J Clin Invest | Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. | 2008 | Details |
A00114 | 18602895 | Biochem Biophys Res Commun | Allele-specific targeting of hsa-miR-657 to human IGF2R creates a potential mechanism underlying the association of ACAA-insertion/deletion polymorphism with type 2 diabetes. | 2008 | Details |
A00115 | 18711366 | Nat Genet | SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. | 2009 | Details |
A00116 | 18711367 | Nat Genet | Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. | 2009 | Details |
A00117 | 1890161 | J Clin Endocrinol Metab | A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman. | 1991 | Details |
A00118 | 18952314 | Trends Genet | Type 2 diabetes: new genes, new understanding. | 2009 | Details |
A00119 | 19020323 | N Engl J Med | Genotype score in addition to common risk factors for prediction of type 2 diabetes. | 2008 | Details |
A00120 | 19020324 | N Engl J Med | Clinical risk factors, DNA variants, and the development of type 2 diabetes. | 2008 | Details |
A00121 | 19164855 | J Clin Invest | Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. | 2009 | Details |
A00122 | 19602480 | Hum Mol Genet | Tissue-specific alternative splicing of TCF7L2. | 2010 | Details |
A00123 | 1963473 | Mol Endocrinol | Functional properties of a naturally occurring Trp1200----Ser1200 mutation of the insulin receptor. | 1991 | Details |
A00124 | 19639018 | Nat Rev Nephrol | HNF1B-related diabetes triggered by renal transplantation. | 2009 | Details |
A00125 | 19657112 | N Engl J Med | Sex hormone-binding globulin and risk of type 2 diabetes in women and men. | 2009 | Details |
A00126 | 19689793 | BMC Med Genomics | MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 Diabetes. | 2009 | Details |
A00127 | 19933169 | Hum Mol Genet | Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. | 2010 | Details |
A00128 | 20016592 | Nature | Parental origin of sequence variants associated with complex diseases. | 2010 | Details |
A00129 | 20085713 | Am J Hum Genet | Identification of KCNJ15 as a susceptibility gene in Asian patients with type 2 diabetes mellitus. | 2010 | Details |
A00130 | 20118932 | Nat Genet | A map of open chromatin in human pancreatic islets. | 2010 | Details |
A00131 | 20353613 | Genome Med | Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. | 2011 | Details |
A00132 | 20360734 | Nature | Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. | 2010 | Details |
A00133 | 20427569 | Mol Biol Cell | Role of Hsp90 in biogenesis of the beta-cell ATP-sensitive potassium channel complex. | 2010 | Details |
A00134 | 20574426 | J Hum Genet | The GCKR rs780094 polymorphism is associated with susceptibility of type 2 diabetes, reduced fasting plasma glucose levels, increased triglycerides levels and lower HOMA-IR in Japanese population. | 2011 | Details |
A00135 | 20651284 | Circ Res | Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. | 2010 | Details |
A00136 | 21118154 | Biochem J | LKB1 is required for hepatic bile acid transport and canalicular membrane integrity in mice. | 2011 | Details |
A00137 | 21186350 | Nat Genet | Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. | 2011 | Details |
A00138 | 21364139 | JAMA | Functional variants of the HMGA1 gene and type 2 diabetes mellitus. | 2011 | Details |
A00139 | 21536946 | Diabetes | Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1. | 2011 | Details |
A00140 | 21673050 | Genome Res | Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. | 2012 | Details |
A00141 | 22286214 | Nat Genet | Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. | 2012 | Details |
A00142 | 22929189 | Orphanet J Rare Dis | Inherited cobalamin malabsorption. Mutations in three genes reveal functional and ethnic patterns. | 2013 | Details |
A00143 | 23275527 | J Clin Endocrinol Metab | Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. | 2013 | Details |
A00144 | 24193408 | Pflugers Arch | Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin. | 2015 | Details |
A00145 | 24390345 | Nature | Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. | 2014 | Details |
A00146 | 24463454 | J Clin Invest | Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. | 2014 | Details |
A00147 | 24518126 | Am J Kidney Dis | Chronic kidney pain in autosomal dominant polycystic kidney disease: a case report of successful treatment by catheter-based renal denervation. | 2014 | Details |
A00148 | 24584071 | Nat Genet | Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. | 2014 | Details |
A00149 | 24897035 | Kidney Int | The HNF1B score is a simple tool to select patients for HNF1B gene analysis. | 2015 | Details |
A00150 | 24904092 | J Am Soc Nephrol | Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. | 2015 | Details |
A00151 | 24994926 | J Am Soc Nephrol | Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model. | 2015 | Details |
A00152 | 25349199 | J Am Soc Nephrol | A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. | 2015 | Details |
A00153 | 25536396 | Nat Rev Nephrol | HNF1B-associated renal and extra-renal disease-an expanding clinical spectrum. | 2015 | Details |
A00154 | 25646624 | PLoS One | An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease. | 2016 | Details |
A00155 | 25741167 | World J Gastroenterol | Hepatic phenotypes of HNF1B gene mutations: a case of neonatal cholestasis requiring portoenterostomy and literature review. | 2015 | Details |
A00156 | 25786098 | Kidney Int | Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. | 2016 | Details |
A00157 | 25894829 | Nat Med | Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. | 2015 | Details |
A00158 | 26150605 | J Am Soc Nephrol | The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease. | 2016 | Details |
A00159 | 26340261 | Am J Nephrol | Hypomagnesemia as First Clinical Manifestation of ADTKD-HNF1B: A Case Series and Literature Review. | 2016 | Details |
A00160 | 26551672 | Nat Genet | Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. | 2016 | Details |
A00161 | 26912555 | Clin J Am Soc Nephrol | Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4. | 2017 | Details |
A00162 | 2695375 | Diabetes | Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. | 1990 | Details |
A00163 | 27188453 | Eur J Endocrinol | Clinical and genetic characterization of congenital hyperinsulinism in Spain. | 2017 | Details |
A00164 | 27398621 | Nature | The genetic architecture of type 2 diabetes. | 2016 | Details |
A00165 | 27484667 | Nephrol Dial Transplant | Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial. | 2018 | Details |
A00166 | 27615128 | Diabetes Obes Metab | The role of hepatocyte nuclear factor 1β in disease and development. | 2017 | Details |
A00167 | 27896077 | Mol Genet Metab Rep | Sequencing analysis of insulin receptor defects and detection of two novel mutations in <i>INSR</i> gene. | 2020 | Details |
A00168 | 27908292 | Orphanet J Rare Dis | Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time. | 2017 | Details |
A00169 | 28132686 | Am J Hum Genet | Decreased STARD10 Expression Is Associated with Defective Insulin Secretion in Humans and Mice. | 2017 | Details |
A00170 | 28215227 | Adv Protein Chem Struct Biol | Elucidating the Mutational Landscape in Hepatocyte Nuclear Factor 1β (HNF1B) by Computational Approach. | 2017 | Details |
A00171 | 28838955 | J Am Soc Nephrol | Bosutinib versus Placebo for Autosomal Dominant Polycystic Kidney Disease. | 2017 | Details |
A00172 | 29361385 | J Formos Med Assoc | Mutation screening of INS and KCNJ11 genes in Taiwanese children with type 1B diabetic onset before the age of 5 years. | 2018 | Details |
A00173 | 29395486 | Am J Kidney Dis | The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 Mutations. | 2019 | Details |
A00174 | 29471960 | Nefrologia (Engl Ed) | Overview of autosomal dominant polycystic kidney disease in the south of Spain. | 2018 | Details |
A00175 | 29674338 | Clin J Am Soc Nephrol | Prevalence of Hypertension in Children with Early-Stage ADPKD. | 2019 | Details |
A00176 | 29751826 | BMC Med Genet | Possible association between ABCC8 C49620T polymorphism and type 2 diabetes in a Nigerian population. | 2019 | Details |
A00177 | 30422235 | JAMA | Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial. | 2018 | Details |
A00178 | 30927425 | Hum Reprod | Factors influencing the clinical outcome of preimplantation genetic testing for polycystic kidney disease. | 2020 | Details |
A00179 | 30951521 | PLoS Med | Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial. | 2019 | Details |
A00180 | 31118516 | Nature | Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. | 2019 | Details |
A00181 | 31676859 | Nat Genet | Loss of ZnT8 function protects against diabetes by enhanced insulin secretion. | 2020 | Details |
A00182 | 31740684 | Sci Rep | Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing. | 2020 | Details |
A00183 | 32398770 | Genet Med | Matching clinical and genetic diagnoses in autosomal dominant polycystic kidney disease reveals novel phenocopies and potential candidate genes. | 2021 | Details |
A00184 | 32631624 | Kidney Int | Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease. | 2021 | Details |
A00185 | 32634120 | JCI Insight | The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD. | 2021 | Details |
A00186 | 32939031 | Genet Med | Clinical impact of genomic testing in patients with suspected monogenic kidney disease. | 2021 | Details |
A00187 | 33097957 | Nephrol Dial Transplant | Mutations in transcription factor CP2-like 1 may cause a novel syndrome with distal renal tubulopathy in humans. | 2021 | Details |
A00188 | 33141305 | Clin Exp Nephrol | Effect of tolvaptan on renal involvement in patients with autosomal dominant polycystic kidney disease according to different gene mutations. | 2021 | Details |
A00189 | 33164752 | Elife | The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus. | 2021 | Details |
A00190 | 33434175 | Endocrinol Diabetes Metab Case Rep | A novel splice-site mutation of the HNF1B gene in a family with maturity onset diabetes of the young type 5 (MODY5). | 2024 | Details |
A00191 | 33853507 | Nucleosides Nucleotides Nucleic Acids | Association of common genetic variants of <i>KCNJ11</i> gene with the risk of type 2 diabetes mellitus. | 2024 | Details |
A00192 | 34145744 | Am J Med Genet A | Homozygous WNT9B variants in two families with bilateral renal agenesis/hypoplasia/dysplasia. | 2022 | Details |
A00193 | 36646975 | Pediatr Nephrol | Dual diagnosis of autosomal dominant polycystic kidney disease and sickle cell disease in a teenage male. | 2023 | Details |
A00194 | 39660790 | J Med Econ | Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Canada. | 2024 | Details |
A00195 | 39684653 | Int J Mol Sci | Pharmacological Nephroprotection in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus-Clinical Practice Position Statement of the Polish Society of Nephrology. | 2024 | Details |
A00196 | 39704168 | JCI Insight | Fasting substrates predict chronic kidney disease progression in CREDENCE trial patients with type 2 diabetes. | 2024 | Details |
A00197 | 39731488 | Malays J Pathol | MACB CKD Task Force updated recommendations for reporting estimated glomerular filtration rate and albuminuria in adults. | 2024 | Details |
A00198 | 39746795 | Ren Fail | Dapagliflozin improves diabetic kidney disease by inhibiting ferroptosis through β-hydroxybutyrate production. | 2025 | Details |
A00199 | 39783822 | J Med Econ | Cost-effectiveness of finerenone therapy for patients with chronic kidney disease and type 2 diabetes in England & Wales: results of the FINE-CKD model. | 2025 | Details |
A00200 | 39804512 | Langenbecks Arch Surg | A hypocaloric protein-rich diet before metabolic surgery improves liver function in patients with obesity and diabetes : A secondary analysis of a randomized clinical trial. | 2025 | Details |